Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
07:36am, Monday, 08'th Feb 2021
WALTHAM, Mass. and HALLE (Saale), Germany, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Prot
Repligen (RGEN) Outpaces Stock Market Gains: What You Should Know
06:56pm, Friday, 05'th Feb 2021
Repligen (RGEN) closed the most recent trading day at $222.06, moving +1.9% from the previous trading session.
Repligen Stock Doubled In 2020 — Why Covid Demand Is Fueling It
12:33pm, Thursday, 04'th Feb 2021
When it comes to coronavirus vaccines, think of Repligen as the man behind the curtain and RGEN stock as a tools powerhouse. Shares broke out of a cup base in January and hover in a buy zone.
Stock Market Analysis: Nasdaq Pullback Healthy; SolarEdge, Yatsen IPO Dive, Repligen In Buy Zone
04:06pm, Friday, 15'th Jan 2021
Stock market analysis: Nasdaq pullback healthy; SolarEdge, Yatsen IPO dive, Repligen in buy zone. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock
Here's Why You Should Really Own Repligen in 2021
05:30pm, Wednesday, 13'th Jan 2021
The tailwinds behind the company's gains aren't going anywhere.
Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
01:00pm, Monday, 04'th Jan 2021
WALTHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtu
Why Repligen Stock Soared 107% in 2020
10:01am, Friday, 01'st Jan 2021
The bioprocessing technology company gained momentum during the coronavirus pandemic.
4 Healthcare Stocks to Take Care of in 2021 to Boost Portfolio
09:02am, Monday, 21'st Dec 2020
Based on strong fundamentals, here we talk about four healthcare stocks to keep in your watchlist for 2021.
Buy 5 Top Stocks with Strong Earnings Beat Prospects
04:33pm, Thursday, 17'th Dec 2020
Invest in top-ranked stocks that are likely to beat earnings estimates in the upcoming releases.
Is Repligen (RGEN) Stock Outpacing Its Medical Peers This Year?
12:02pm, Tuesday, 15'th Dec 2020
Is (RGEN) Outperforming Other Medical Stocks This Year?
Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters' Option
04:18pm, Thursday, 10'th Dec 2020
WALTHAM, Mass., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the closing of its previously announced underwritten public offering of an aggregate of 1.725 mill
Repligen Corporation Prices Public Offering of Shares of Common Stock
09:41pm, Monday, 07'th Dec 2020
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the pricing of an underwritten public offering of 1.5 million shares of its common stock at a publ
Repligen: A Cure For COVID-19
10:21am, Monday, 07'th Dec 2020
Repligen is a "pick-and-shovel" play in the bioprocessing industry. Repligen heavily invests in single-use products for use in downstream continuous manufacturing processes, which are two of the late
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
07:22am, Monday, 07'th Dec 2020
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that it has commenced an underwritten public offering of 1.5 million shares of its common stock. I
Repligen (RGEN) Looks Good: Stock Adds 6.1% in Session
08:31am, Friday, 13'th Nov 2020
Repligen (RGEN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
